Vanderbilt Ingram Cancer Center

For more VICC news, visit their website »

September 29, 2022

Policy, resources crucial for lung cancer screening: study

Vanderbilt reseach shows that resources for lung cancer screening programs increased the number of veterans screened.

By Leigh MacMillan
(iStock)
September 29, 2022

Vanderbilt lauded for pancreatic cancer, pancreatitis care

Vanderbilt has been recognized as a National Pancreas Foundation Center of Excellence.

By Tom Wilemon
September 22, 2022

Nerve cells and cancer progression

Immature nerves and neural precursor cells increase in density as a type of premalignant tumor in the pancreas progresses to invasive disease, suggesting that blocking these cells may arrest malignant progression.

By Leigh MacMillan
Members of the newly named MASLAB gathered for a portrait on the Medical Center Plaza. The early lung cancer detection research initiative was named in honor of the late Pierre Massion, MD.
September 15, 2022

Lung cancer detection program lands grant renewal

The National Cancer Institute has renewed funding for the Early Detection Research Network Lung Cancer Clinical Validation Center at Vanderbilt- Ingram Cancer Center.

By Tom Wilemon
September 13, 2022

Patients had ‘significant and clinically meaningful improvement’ in survival in fruquintinib clinical trial

Patients with metastatic colorectal cancer who had not responded to other treatments had “significant and clinically meaningful improvement” in overall survival when treated with the oral targeted therapy fruquintinib.

By Tom Wilemon
September 13, 2022

Cancer registries and sarcoma research

The number of sarcoma research studies that use the two largest U.S. cancer registries is increasing, but over one-third of studies that asked the same research question reported conflicting findings.

By Leigh MacMillan
September 1, 2022

Grant supports research to study gastric cancer origins

Vanderbilt researchers have received $5 million in funding from a new initiative by the National Cancer Institute that aims to define how gastric and gastroesophageal junction adenocarcinomas form and evolve at the cellular level.
By Tom Wilemon
September 1, 2022

Chic Aweareness ovarian cancer fundraiser moves online

Chic Awearness, a fundraiser for ovarian cancer research at Vanderbilt-Ingram Cancer Center (VICC), is an online event this year from now throughout September with an in-store shopping opportunity to close out the month called Chic Week.
By Tom Wilemon
August 29, 2022

Blood cancer progression

Vanderbilt researchers used single-cell technologies to explore the accumulation of mutations during blood cancer progression, which could help identify strategies for preventing leukemia before it occurs.
By Leigh MacMillan
August 25, 2022

New high-tech biobank safeguards critical specimens

By Bill Snyder
August 25, 2022

V Foundation support

Shane Jacobson, chief executive officer of the V Foundation for Cancer Research, on left, visited Vanderbilt-Ingram Cancer Center on Monday to meet with former and current recipients of funding from the foundation.
By VUMC News and Communications
August 18, 2022

Abramson, Eng, Johnson named to new VICC roles

Three physician researchers at Vanderbilt-Ingram Cancer Center are assuming additional leadership roles.
By Tom Wilemon
August 17, 2022

Trial for colorectal cancer drug reaches primary endpoint

A new therapy for metastatic colorectal cancer that has been granted fast track designation by the U.S. Food and Drug Administration has met its primary endpoint of overall survival in a phase 3 clinical trial.
By Tom Wilemon
1 … 4 5 6 7 8 … 58